AMPH
Price
$25.43
Change
+$0.08 (+0.32%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.17B
38 days until earnings call
Intraday BUY SELL Signals
COLL
Price
$22.05
Change
+$0.21 (+0.96%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
736.73M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMPH vs COLL

AMPH vs COLL Comparison Chart in %
View a ticker or compare two or three
VS
AMPH vs. COLL commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a StrongBuy and COLL is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AMPH vs COLL: Fundamental Ratings
AMPH
COLL
OUTLOOK RATING
1..100
7714
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
9096
SMR RATING
1..100
6950
PRICE GROWTH RATING
1..100
3985
P/E GROWTH RATING
1..100
1187
SEASONALITY SCORE
1..100
759

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (62) in the Pharmaceuticals Other industry is in the same range as COLL (63). This means that AMPH’s stock grew similarly to COLL’s over the last 12 months.

AMPH's Profit vs Risk Rating (90) in the Pharmaceuticals Other industry is in the same range as COLL (96). This means that AMPH’s stock grew similarly to COLL’s over the last 12 months.

COLL's SMR Rating (50) in the Pharmaceuticals Other industry is in the same range as AMPH (69). This means that COLL’s stock grew similarly to AMPH’s over the last 12 months.

AMPH's Price Growth Rating (39) in the Pharmaceuticals Other industry is somewhat better than the same rating for COLL (85). This means that AMPH’s stock grew somewhat faster than COLL’s over the last 12 months.

AMPH's P/E Growth Rating (11) in the Pharmaceuticals Other industry is significantly better than the same rating for COLL (87). This means that AMPH’s stock grew significantly faster than COLL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHCOLL
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
70%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
78%
Bullish Trend 12 days ago
69%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 3 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (AMPH: $25.35 vs. COLL: $21.84)
Brand notoriety: AMPH and COLL are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AMPH: 122% vs. COLL: 110%
Market capitalization -- AMPH: $1.17B vs. COLL: $736.73M
AMPH [@Pharmaceuticals: Generic] is valued at $1.17B. COLL’s [@Pharmaceuticals: Generic] market capitalization is $736.73M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 1 FA rating(s) are green while COLL’s FA Score has 0 green FA rating(s).

  • AMPH’s FA Score: 1 green, 4 red.
  • COLL’s FA Score: 0 green, 5 red.
According to our system of comparison, AMPH is a better buy in the long-term than COLL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 4 TA indicator(s) are bullish while COLL’s TA Score has 5 bullish TA indicator(s).

  • AMPH’s TA Score: 4 bullish, 4 bearish.
  • COLL’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, COLL is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Generic) experienced а -3.50% price change this week, while COLL (@Pharmaceuticals: Generic) price change was -3.53% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.75%. For the same industry, the average monthly price growth was -8.05%, and the average quarterly price growth was +29.45%.

Reported Earning Dates

AMPH is expected to report earnings on Nov 09, 2026.

COLL is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.75% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
AMPH
Daily Signal:
Gain/Loss:
COLL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPO179.733.75
+2.13%
XPO
DRMA1.10N/A
N/A
Dermata Therapeutics Inc
SII115.67-3.71
-3.11%
Sprott
BYFC11.46-0.37
-3.13%
Broadway Financial Corp
ABTC8.18-0.30
-3.54%
American Bitcoin Corp

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with AMRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
-1.78%
AMRX - AMPH
45%
Loosely correlated
-0.35%
IXHL - AMPH
40%
Loosely correlated
+0.31%
EBS - AMPH
37%
Loosely correlated
-3.48%
VTRS - AMPH
36%
Loosely correlated
-1.47%
ZTS - AMPH
36%
Loosely correlated
-1.05%
More

COLL and

Correlation & Price change

A.I.dvisor indicates that over the last year, COLL has been loosely correlated with EBS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if COLL jumps, then EBS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COLL
1D Price
Change %
COLL100%
+0.09%
EBS - COLL
40%
Loosely correlated
-3.48%
VTRS - COLL
36%
Loosely correlated
-1.47%
AMRX - COLL
35%
Loosely correlated
-0.35%
AMPH - COLL
34%
Loosely correlated
-1.78%
SNDL - COLL
33%
Loosely correlated
-2.33%
More